OR9
Research OR9 on Bullrun: market cap EUR 97.63K. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerOR9
- ExchangeF
- CountryFrance
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyEUR
- Market capEUR 97.63K
- Financial periodFY2025
- RevenueEUR 5.36M
- Revenue growth6.4%
- Net income-EUR 4.67M
- Free cash flow-EUR 2.15M
- Gross margin67.5%
Valuation Snapshot
latest market cap is EUR 97.63K.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 5.36M | -EUR 4.67M | -EUR 2.15M | 67.5% | -0.02 | EUR 390.00K | EUR 13.50M | -EUR 10.68M |
| FY2024 | EUR 5.04M | -EUR 1.93B | -EUR 3.36M | 52.6% | n/a | EUR 317.00K | EUR 11.79M | -EUR 8.42M |
| FY2023 | EUR 5.81M | -EUR 205.44M | EUR 64.69M | 74.4% | n/a | EUR 780.00K | EUR 271.21M | -EUR 202.36M |
| FY2022 | EUR 5.86M | -EUR 6.97M | -EUR 6.33M | 67.0% | -90 | EUR 302.00K | EUR 10.11M | -EUR 1.28M |
| FY2021 | EUR 4.56M | -EUR 6.71M | -EUR 8.22M | 56.6% | -31190999688.09 | EUR 913.00K | EUR 8.86M | EUR 396.00K |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-14 | EUR 97.63K | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About OR9
Safe Orthopaedics SA, a medical technology company, develops and markets ready-to-use implants and sterile instrumentation for spinal surgery in France. It offers SteriSpine PS, an all-round kit for open, mini open, and MIS surgeries, as well as percutaneous kit; SteriSpine VA, a product platform for ready to use Kyphoplasty and Cement systems; SteriSpine LC, a ready to use instrumentation for lumbar cage portfolio, including Cedar and Elm;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is OR9's market cap?
OR9's market capitalization is EUR 97.63K.
What does OR9 do?
Safe Orthopaedics SA, a medical technology company, develops and markets ready-to-use implants and sterile instrumentation for spinal surgery in France. It offers SteriSpine PS, an all-round kit for open, mini open, and MIS surgeries, as well as percutaneous kit; SteriSpine VA, a product platform for ready to use Kyphoplasty and Cement systems; SteriSpine LC, a ready to use instrumentation for lumbar cage portfolio, including Cedar and Elm; and SteriSpine CC, a ready to use instrumentation for cervical cage, such as Walnut.